These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12122498)

  • 1. Local administration of ETA (but not ETB) blockers into the PAG area of the brain decreases blood pressure of DOCA-salt rats.
    Di Filippo C; D'Amico M; Piegari E; Rinaldi B; Filippelli A; Rossi F
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):123-6. PubMed ID: 12122498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonists reduce the pressor effects of angiotensin II into the periaqueductal gray area of rats.
    D'Amico M; Di Filippo C; Filippelli A; Rossi F
    Life Sci; 1999; 65(9):PL95-9. PubMed ID: 10465357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
    Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETA endothelin receptors are involved in the ouabain-induced haemodynamic effects in the periaqueductal gray area of rats.
    D'Amico M; Di Filippo C; Piegari E; Rinaldi B; Rossi F; Filippelli A
    Life Sci; 2003 Apr; 72(20):2211-8. PubMed ID: 12628441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
    Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central endothelin ET
    Guil MJ; Soria C; Seijas M; Bianciotti LG; Vatta MS
    Eur J Pharmacol; 2020 Oct; 885():173543. PubMed ID: 32896551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressor responses to endothelin-1 into the superior colliculus of rats: predominant role of endothelin ET(B) receptors.
    D'Amico M; Di Filippo C; Rossi F
    Eur J Pharmacol; 1998 Apr; 347(1):71-5. PubMed ID: 9650850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic peripheral ouabain treatment affects the brain endothelin system of rats.
    Di Filippo C; Filippelli A; Rinaldi B; Piegari E; Esposito F; Rossi F; D'Amico M
    J Hypertens; 2003 Apr; 21(4):747-53. PubMed ID: 12658021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of endothelin-1 into the raphe obscurus of rats induces depressor responses predominantly through endothelin ET(A) receptors.
    D'Amico M; Di Filippo C; Esposito F; Rossi F; Filippelli A
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):471-6. PubMed ID: 10431758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and non-selective ET antagonists reveal an ETB receptors mediated ET-1-induced behavioural effect in conscious rats.
    D'Amico M; Berrino L; Maione S; Rossi F
    Life Sci; 1996; 58(10):PL 177-80. PubMed ID: 8602109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R; Sventek P; Thibault G; Schiffrin EL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
    Hashimoto N; Kuro T; Fujita K; Azuma S; Matsumura Y
    Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
    Johnson RJ; Galligan JJ; Fink GD
    J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
    J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
    Matsumura Y; Hashimoto N; Fujita K; Morimoto S
    Eur J Pharmacol; 1997 Jan; 319(1):65-9. PubMed ID: 9030899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.